SCHEMBL17984615

SCHEMBL17984615

CC(=O)Nc1ccc2c(C#N)noc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA9 Q16790 1/20 0.47
ALDH1A1 P00352 3/20 0.45
MAP2K1 Q02750 1/20 0.43
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.41
GLA P06280 1/20 0.41
TNNI3 P19429 1/20 0.41
TNNT2 P45379 1/20 0.41
TNNC1 P63316 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025539 0.80 CA12 (0.55) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL7902665 0.78 CA12 (0.50) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL17454400 0.78 HIF1A (0.50) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL16571762 0.76 CA12 (0.48) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL16571545 0.75 HIF1A (0.50) CA12CA1CA9MAP2K1BCHE
SCHEMBL17984566 0.74 CA12 (0.46) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL20229888 0.74 POLB (0.49) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL17452810 0.74 CA12 (0.46) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL17307543 0.71 CA12 (0.48) CA12CA1CA9ALDH1A1MAP2K1
SCHEMBL8351343 0.67 ALDH1A1 (0.79) CA12CA1CA9ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160237059-A1 HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237059-A1 HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE REN, GLS, FIBP CA12 4857/4885CA1 4874/4885CA9 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.